Psychiatric Comorbidities in Type 1 Diabetes Mellitus.

NCT06586879 | Not Yet Recruiting

• 1 other identifier: Psychiatry in type 1 DM
• Study Type: observational
• Target: 220
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study aimed to assess the prevalence of psychiatric comorbidities in children and adolescents with diabetes mellitus type 1. Assessing the impact of diabetes mellitus type 1 on quality of life. And determine the effect of associated factors on the development of psychiatric comorbidities and on quality of life in diabetes mellitus type 1.

Conditions

Type 1 Diabetes Mellitus

Outcome Measures

Primary Outcomes (2)

• The prevalence of psychiatric comorbidities in children and adolescents with diabetes mellitus type 1.

  This outcome will be measured using: The Kiddie-Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime (K-SADS-PL) version

  2 years

• the prevalence of depression, anxiety and sleep disorder in children and adolescents with diabetes mellitus type 1

  this outcome will be measured using: 1. Children's Depression Inventory 2 Self Report-Short (CDI-2) (12) 2. The Spence Children's Anxiety Scale 3. Children's Sleep Habits Questionnaire (CSHQ)

  2 years

Secondary Outcomes (1)

• The impact of diabetes mellitus type 1 on quality of life.

  2 years

Eligibility Criteria

• Age: 8 Years - 15 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Probability Sample

Study Population

Children and adolescent Patients with type 1 diabetes medllitus aged 8-15 years old.

You may qualify if:

• Children and adolescents aged between 8 and 15 years, diagnosed with diabetes mellitus type 1 and on medical treatment.

You may not qualify if:

• Patients with major psychiatric disorders or have cognitive difficulties.
• Patients unable or refuse to give consent.

Sponsors & Collaborators

• Assiut University: lead

Related Publications (3)

• Ashraf MN, Cheng AYY, Robinson DJ. Emotional, Psychological, and Social Well-being Experience of Long-Term Living with Type 1 Diabetes Mellitus: A Patient-Psychiatrist-Endocrinologist Perspective. Diabetes Ther. 2024 Feb;15(2):317-323. doi: 10.1007/s13300-023-01527-w. Epub 2024 Jan 17.

  PMID: 38233629 BACKGROUND

• Abouzid MR, Ali K, Elkhawas I, Elshafei SM. An Overview of Diabetes Mellitus in Egypt and the Significance of Integrating Preventive Cardiology in Diabetes Management. Cureus. 2022 Jul 20;14(7):e27066. doi: 10.7759/cureus.27066. eCollection 2022 Jul.

  PMID: 36000101 BACKGROUND

• El-Ziny MA, Salem NA, El-Hawary AK, Chalaby NM, Elsharkawy AA. Epidemiology of childhood type 1 diabetes mellitus in Nile Delta, northern Egypt - a retrospective study. J Clin Res Pediatr Endocrinol. 2014;6(1):9-15. doi: 10.4274/Jcrpe.1171.

  PMID: 24637304 BACKGROUND

Related Links

• Type 1 diabetes in international diabetes Federation
• Type 1 diabetes index
• Psychological care of children and adolescents with type 1 diabetes
• Evaluation of psychological characteristics of Turkish children with type 1 diabetes mellitus from two demographically and geographically distinct regions
• The cognitive and psychological effects of living with type 1 diabetes
• High Rate of Depression among Saudi Children with Type 1 Diabetes
• Updating and validation of the socioeconomic status scale for health research in Egypt
• Type 1 Diabetes
• Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data
• Children's Depression Inventory 2nd Edition
• A measure of anxiety symptoms among children
• CHILDREN'S SLEEP HABITS QUESTIONNAIRE (ABBREVIATED)
• The PedsQL 4.0 Generic Core Scales:

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Autoimmune Diseases; Immune System Diseases

Study Officials

• Dalia Mahran

  Assiut University

  STUDY DIRECTOR

Central Study Contacts

Omnia Fath-Allah, Physician

CONTACT

+201012304476; omnaya.16266093@med.aun.edu.eg

Study Design

• Study Type: observational
• Observational Model: CASE CROSSOVER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident doctor

Study Record Dates

• First Submitted: August 27, 2024
• First Posted: September 19, 2024
• Study Start: October 1, 2024
• Primary Completion (Estimated): September 1, 2026
• Study Completion (Estimated): September 1, 2026
• Last Updated: September 19, 2024

Record last verified: 2024-09

Data Sharing

• IPD Sharing: Will not share